Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by Sabra Healthcare in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Sabra Healthcare’s 10-Q, filed April 29, 2026.
- Filed
- Apr 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001492298-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Interest and other income | 10,018 | 10,059 |
| Total revenues | 221,753 | 183,543 |
| Expenses: | ||
| Depreciation and amortization | 53,131 | 43,494 |
| Interest | 28,409 | 27,100 |
| Triple-net portfolio operating expenses | 3,773 | 3,479 |
| Senior housing - managed portfolio operating expenses | 81,869 | 56,454 |
| General and administrative | 14,862 | 12,728 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Sabra Healthcare's D&A?
- Sabra Healthcare (SBRA) reported D&A of $53.13M in Q1 2026.
- How has Sabra Healthcare's D&A changed year-over-year?
- Sabra Healthcare's D&A increased by 22.2% year-over-year, from $43.49M to $53.13M.
- What is the long-term trend for Sabra Healthcare's D&A?
- Over 4 years (2021 to 2025), Sabra Healthcare's D&A has grown at a 1.1% compound annual growth rate (CAGR), from $178.99M to $187M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about Sabra Healthcare's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude